An Efficient Synthesis of Acenaphtho[1,2-b]indole Derivatives via Domino Reaction.

A concise and efficient synthesis of acenaphtho[1,2-b]indole derivatives via the domino reactions of enaminones with acenaphthoquinone catalyzed by l-proline has been developed. This protocol has the advantages of good yields, operational convenience and high regioselectivity.

1. Introduction

The indole skeleton is often considered to be one of the most important and fascinating classes of nitrogen-containing heterocycles, and it is often found in both natural products and biologically active compounds [1]. Many indole derivatives have a wide range of biological activities, including anticancer, antioxidant, anti-inflammatory and anti-HIV effects [2,3,4,5,6,7]. In addition, various polycyclic indoles are privileged scaffolds in medicinal chemistry and drug discovery [8,9,10,11]. As a result of these interesting biological activities, many powerful approaches have been developed for the construction of polycyclic indole moieties [12,13,14,15,16,17,18]. However, many of these methods have drawbacks, such as limited availability of starting materials, the use of expensive metal catalysts and the need for harsh reaction conditions. Therefore, developing new and efficient methods for the synthesis of polycyclic indoles and their functionalized derivatives using readily available starting materials is of great importance. Enaminones are commercially available starting materials and have proven to be a useful synthons in the construction of a variety of diverse heterocycles. This synthons has been used in the construction of indole moiety via the condensation with α,β-dicarbonyl compounds under catalyst-free [19,20] or acidic catalyst [21] conditions.

Domino (cascade) reactions are promising and powerful tools in organic and medical chemistry because of their high atom economy, highly complex and diverse products, efficiency in forming multiple bonds, and environmental friendliness [22]. Consequently, domino reactions have often been used for the construction of complex heterocycles [23,24,25,26,27,28]. As part of our program to develop new methods for the construction of important heterocycles by domino reactions [29,30,31,32], we report herein an efficient synthesis of acenaphtho[1,2-b]indole derivatives via a domino reaction using l-proline as the catalyst.

2. Results and Discussion

We initially evaluated the domino reaction of enaminone 1a and acenaphthoquinone (2). The reaction mixture of 1a and 2 (1:1 in mole) was subjected to a variety of different conditions and the results are summarized in Table 1. Target product 3a was obtained in 19% yield when the reaction was carried out under catalyst-free conditions in ethanol at reflux for 2 h followed by dehydroxylation catalyzed by acid (Table 1, entry 1). To our delight, when l-proline (10 mol %) was added, the yield increased to 41% (Table 1, entry 2). Next several other solvents were evaluated for their ability to improve the yield further. The results indicated that toluene was superior to ethanol, chloroform, THF, 1,4-dioxane, DMF, and water in providing much better results (Table 1, entries 2-8). A number of different catalysts were also evaluated for their catalytic efficiency in this reaction. In all cases, the reaction was carried out with 10 mol % of the catalyst in toluene at 80 °C for 2 h. The results revealed that l-proline provided much better results than p-TSA, S-phenylalanine, phenylalanine, pyrrolidine, piperidine, benzylamine and dibenzylamine (Table 1, entries 9–15). These results indicated that the presence of both secondary nitrogen and a carboxylic acid group plays a crucial role in the desird catalytic activity.

Table 1

Optimization of the reaction conditions.

Entry	Solvent	Catalyst (mol %)	Temperature (°C)	Yield (%)
1	Ethanol	No	Reflux	19
2	Ethanol	L-Proline (10)	Reflux	41
3	Chloroform	L-Proline (10)	Reflux	28
4	THF	L-Proline (10)	Reflux	40
5	1,4-Dioxane	L-Proline (10)	Reflux	23
6	DMF	L-Proline (10)	80	42
7	Water	L-Proline (10)	80	20
8	Toluene	L-Proline (10)	80	65
9	Toluene	p-TSA (10)	80	46
10	Toluene	S-Phenylalanine (10)	80	18
11	Toluene	Phenylamine (10)	80	30
12	Toluene	Pyrrolidine(10)	80	56
13	Toluene	Piperidine(10)	80	60
14	Toluene	Benzylamine(10)	80	40
15	Toluene	Dibenzylamine(10)	80	63
16	Toluene	L-Proline (5)	80	45
17	Toluene	L-Proline (15)	80	59
18	Toluene	L-Proline (20)	80	45
19	Toluene	L-Proline (10)	40	Trace
20	Toluene	L-Proline (10)	60	25
21	Toluene	L-Proline (10)	Reflux	80

Reactions were performed using 1a (1 mmol), 2 (1 mmol) in solvent (5 mL).

After l-proline had been identified as the best organocatalyst for this reaction, we decided to test the amount of this catalyst required for the full transformation to the desired compounds. The results revealed that when the amount of l-proline increased from 5 mol % to 10 mol %, the yield also increased from 45 to 65% (Table 1, entries 16 and 8). The use of 10 mol % of l-proline in toluene was effective in pushing this reaction forward, and using larger amounts of the catalyst did not improve the yields (Table 1, entries 17–18). The optimization process revealed that the reaction could not proceed in toluene at 40 °C (Table 1, entry 19). To identify the optimum reaction temperature, the reaction was conducted in toluene in the presence of 10 mol % l-proline at 60 °C, 80 °C, and reflux, and these reactions provided product 3a in yields of 25, 65 and 80% (Table 1, entries 20, 8 and 21), respectively. On the basis of these results, the optimum reaction condition was identified as refluxing with 10 mol % l-proline in toluene for 2 h. Compared with other catalysts (for example, p-TSA and TEA), this catalyst has the advantages of higher catalytic efficiency, less toxicity, low cost and ready availability

After the reaction conditions were optimized, the substrate scope of this transformation was also investigated. As shown in Table 2, acenaphthequinone and methyl, bromo, chloro, t-Bu and fluoro substituents on the enaminone ring were well tolerated under the reaction conditions, yielding products in satisfactory yields (up to 85%). However, when the enaminones with a bulkier group at the 2- or 2- and 6- positions were used, none of the desired products was obtained (Table 2, entries 15-16).

Table 2

Synthesis of acenaphtho[1,2-b]indole derivatives 3.

Entry	R1	R2	Product	Yield (%)
1	CH3	4-CH3	3a	80
2	CH3	3-Cl-4-F	3b	82
3	CH3	4-CH3O	3c	85
4	CH3	4-Br	3d	76
5	CH3	4-NO2	3e	70
6	CH3	3,5-(CH3)2	3f	78
7	CH3	H	3g	80
8	CH3	2-Cl	3h	82
9	CH3	4-t-Bu	3i	80
10	H	H	3j	84
11	H	2-Cl	3k	79
12	H	2,4-(CH3)2	3l	80
13	H	4-t-Bu	3m	81
14	H	3,5-(CH3)2	3n	83
15	CH3	2-t-Bu	3o	trace
16	CH3	2,6-(t-Bu)2	3p	trace

The structures of compounds 3 were characterized by IR, 1H-NMR, and 13C-NMR spectra as well as HRMS. The structure of 3g was further confirmed using single-crystal X-ray diffraction analysis, (Figure 1).

Figure 1

Crystal structure of compound 3g.

Although details of the mechanism of the domino reaction remain unclear, the formation of compound 3 could be explained by the reaction sequence shown in Scheme 1. The initial reversible reaction of acenaphthoquinone (2) with l-proline would give iminium ion A. Then, an aza-ene addition of enaminone 1 to iminium ion A leads to intermediate B, which would undergo a rapid tautomerization to give intermediate C. Intermediate E would be formed by the intramolecular cyclization of intermediate C and the elimination of l-proline. Then, intermediate F would be generated by the nucleophilic addition of water to intermediate E. In the last step, product 3 would be formed by dehydroxylation of the intermediate catalyzed by H2SO4 in acetic acid solution.

Scheme 1

Proposed mechanism of the synthesis of acenaphtho[1,2-b]indole derivatives 3.

To support the proposed reaction mechanism, several control experiments were performed (Scheme 2). For example, intermediate Fa was obtained in 84% yield from the reaction of 1a with 2 in refluxing toluene for 2 h catalyzed by 10 mol % l-proline. Desired product 3a was obtained in 90% yield when intermediate Fa was reacted at 80 °C for 2 h in acetic acid catalyzed by H2SO4.

Scheme 2

Preliminary mechanism study.

3. Experimental

3.1. General Information

All chemicals were obtained commercially and used without further purification. Melting points were measured using an XT-5 micro melting point apparatus from Beijing Tech Instrument Co., Ltd., (Beijing, China) and are uncorrected. NMR spectra were recorded in DMSO-d6 or CDCl3 solution on Inova-300 or 400 MHz spectrometers (Varian, Palo Alto, CA, USA). Chemical shifts values are given in ppm and referred as the internal standard to TMS (tetramethylsilane). The coupling constants (J) are reported in hertz (Hz). High-resolution mass spectra (HRMS) were obtained using a MicrOTOF-Q II instrument from Bruker (Billerica, MA, USA). X-ray crystal diffraction analysis was performed with a Mercury CCD X-ray diffractometer (Rigaku, Akishima, Tokyo, Japan).

3.2. General Procedure for the Synthesis of Acenaphtho[1,2-b]indole Derivatives 3

A mixture of enaminone 1 (1.0 mmol), acenaphthoquinone (2, 1.0 mmol), l-proline (0.1 mmol) and toluene (5 mL) was refluxed for 1–3 h. After the completion of the reaction (confirmed by TLC), the reaction mixture was concentrated in vacuo. Then, acetic acid (15 mL) and conc. H2SO4 (0.5 mL) were added. The reaction mixture was stirred at 80 °C for 1–2 h. After completion of the reaction (confirmed by TLC), the reaction mixture was then cooled to room temperature and concentrated in vacuo. The crude mixture was purified by column chromatography on silica gel using ethyl acetate/petroleum ether 1:3 as the eluents to give the corresponding product 3.

9,9-Dimethyl-7-(p-tolyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3a). White solid, R = 0.56, m.p. 214–216 °C. IR (KBr, cm−1) ν: 3063, 2951, 1724, 1630, 1504, 1483, 1323, 1259, 1156, 1140, 860, 771, 722, 679. 1H-NMR (400 MHz, CDCl3) δ 8.11 (d, J = 6.4 Hz, 1H, ArH), 7.56 (t, J = 8.8 Hz, 2H, ArH), 7.47 (t, J = 6.8 Hz, 1H, ArH), 7.35–7.33 (m, 4H, ArH), 7.21 (t, J = 7.6 Hz, 1H, ArH), 7.04 (d, J = 6.8 Hz, 1H, ArH), 2.56 (s, 2H, CH2), 2.42 (s, 3H, CH3), 2.40 (s, 2H, CH2), 1.05 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 192.8, 145.5, 138.1, 137.7, 133.7, 131.0, 130.8, 129.3, 128.2, 128.0, 127.1, 125.6, 125.3, 125.0, 124.7, 124.6, 122.8, 117.9, 115.2, 51.1, 36.1, 34.8, 27.6, 20.3. HRMS (ESI) m/z: Calcd. for C27H23NONa [M + Na]+ 400.1677. Found: 400.1705.

7-(3-Chloro-4-fluorophenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3b). White solid, R = 0.61, m.p. 248–250 °C. IR (KBr, cm−1) ν: 3027, 2939, 1721, 1494, 1343, 1174, 895, 818. 1H-NMR (400 MHz, CDCl3) δ 8.18 (d, J = 6.8 Hz, 1H, ArH), 7.69–7.65 (m, 3H, ArH), 7.56 (t, J = 7.6 Hz, 1H, ArH), 7.44–7.31 (m, 3H, ArH), 7.10 (d, J = 6.8 Hz, 1H, ArH), 2.57 (s, 2H, CH2), 2.43 (s, 2H, CH2), 1.12 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.7, 156.3, 146.2, 138.8, 131.7, 131.6, 129.3, 128.5, 128.2, 128.2, 126.7, 126.5, 126.3, 125.9, 125.8, 124.2, 118.7, 117.9, 117.6, 116.6, 51.9, 37.0, 35.9, 28.6. HRMS (ESI) m/z: Calcd. for C26H19ClFNONa [M + Na]+ 438.1037. Found: 438.1020.

7-(4-Methoxyphenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3c). White solid, R = 0.57, m.p. 240–242 °C. IR (KBr, cm−1) ν: 3037, 2944, 1723, 1511, 1443, 1078, 816. 1H-NMR (400 MHz, CDCl3) δ 8.10–8.08 (m, 1H, ArH), 7.58–7.54 (m, 2H, ArH), 7.48–7.46 (m, 1H, ArH), 7.37–7.35 (m, 2H, ArH), 7.23–7.17 (m, 1H, ArH), 7.01–7.00 (m, 3H, ArH), 3.84–3.83 (m, 3H, CH3O), 2.52 (s, 2H, CH2), 2.46 (s, 2H, CH2), 1.04 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.8, 159.6, 146.8, 139.3, 132.1, 131.8, 130.0, 129.2, 129.0, 128.1, 127.1, 126.7, 126.3, 125.9, 125.5, 123.7, 118.8, 116.1, 114.9, 55.6, 52.0, 36.9, 35.7, 28.6. HRMS (ESI) m/z: Calcd. for C27H23NO2Na [M + Na]+ 416.1626. Found: 416.1629.

7-(4-Bromophenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3d). White solid, R = 0.60, m.p. 230–232 °C. IR (KBr, cm−1) ν: 3049, 2952, 1652, 1609, 1494, 1079, 819, 769. 1H-NMR (400 MHz, CDCl3) δ 8.17 (d, J = 6.4 Hz, 1H, ArH), 7.73–7.71 (m, 2H, ArH), 7.67–7.62 (m, 2H, ArH), 7.54 (t, J = 7.6 Hz, 1H, ArH), 7.41–7.39 (m, 2H, ArH), 7.29 (t, J = 7.2 Hz, 1H, ArH), 7.10 (d, J = 6.8 Hz, 1H, ArH), 2.55 (s, 2H, CH2), 2.41 (s, 2H, CH2), 1.10 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.7, 146.2, 138.6, 136.3, 133.0, 131.8, 131.7, 129.3, 128.7, 128.2, 127.4, 126.7, 126.5, 126.2, 126.1, 124.0, 122.4, 118.9, 116.5, 51.9, 37.0, 35.8, 28.6. HRMS (ESI) m/z: Calcd. for C26H20BrNONa [M + Na]+ 464.0626. Found: 464.0633.

9,9-Dimethyl-7-(4-nitrophenyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3e). Yellow solid, R = 0.63, m.p. 240–242 °C. IR (KBr, cm−1) ν: 3036, 2953, 2350, 1728, 1592, 1505, 1329, 1068, 842. 1H-NMR (400 MHz, CDCl3) δ 8.60 (d, J = 7.2 Hz, 1H, ArH), 8.52 (d, J = 8.4 Hz, 1H, ArH), 8.31–8.26 (m, 3H, ArH), 8.09 (d, J = 6.8 Hz, 1H, ArH), 7.84–7.80 (m, 3H, ArH), 7.67 (d, J = 8.0 Hz, 1H, ArH), 2.72 (s, 1H, CH2), 2.51 (s, 1H, CH2), 2.17 (s, 1H, CH2), 1.64 (s, 1H, CH2), 1.25 (s, 3H, CH3), 1.16 (s, 3H, CH3). 13C-NMR (75 MHz, CDCl3) δ 187.1, 159.5, 146.1, 145.0, 141.8, 134.3, 132.4, 131.6, 127.5, 127.4, 126.4, 125.8, 125.6, 125.5, 125.3, 124.4, 123.4, 121.0, 117.9, 117.7, 50.9, 35.0, 28.7, 27.6. HRMS (ESI) m/z: Calcd. for C26H20N2O3Na [M + Na]+ 431.1372. Found: 431.1355.

7-(3,5-Dimethylphenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3f). White solid, R = 0.57, m.p. 220–221 °C. IR (KBr, cm−1) ν: 3076, 2956, 1728, 1638, 1510, 1474, 1383, 1181, 1080, 870, 836, 801, 767. 1H-NMR (400 MHz, CDCl3) δ 8.18 (d, J = 6.4 Hz, 1H, ArH), 7.66–7.62 (m, 2H, ArH), 7.55 (t, J = 7.2 Hz, 1H, ArH), 7.30 (t, J = 7.6 Hz, 1H, ArH), 7.18–7.15 (m, 3H, ArH), 7.11 (d, J = 6.8 Hz, 1H, ArH), 2.65 (s, 2H, CH2), 2.48 (s, 2H, CH2), 2.46 (s, 6H, 2 × CH3), 1.15 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.9, 146.5, 139.7, 139.1, 137.2, 132.1, 130.3, 129.2, 129.1, 128.1, 126.7, 126.3, 126.0, 123.8, 123.4, 118.9, 116.2, 52.1, 37.2, 35.9, 28.6, 21.4. HRMS (ESI) m/z: Calcd. for C28H25NONa [M + Na]+ 414.1834. Found: 414.1847.

9,9-Dimethyl-7-phenyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3g). White solid, R = 0.55, m.p. 200–202 °C. IR (KBr, cm−1) ν: 3042, 2958, 1649, 1520, 1500, 1394, 1081, 821, 774, 706. 1H-NMR (400 MHz, CDCl3) δ 8.13 (d, J = 6.0 Hz, 1H, ArH), 7.60–7.50 (m, 8H, ArH), 7.23 (dd, J = 14.0, 6.8 Hz, 1H, ArH), 7.05 (d, J = 6.4 Hz, 1H, ArH), 2.59 (s, 2H, CH2), 2.42 (s, 2H, CH2), 1.09 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.8, 146.5, 138.9, 137.3, 132.0, 131.8, 129.8, 129.2, 128.9, 128.7, 128.1, 126.7, 126.3, 126.1, 125.8, 123.8, 118.9, 116.3, 52.0, 37.0, 35.8, 28.6. HRMS (ESI) m/z: Calcd. for C26H21NONa [M + Na]+ 386.1521. Found: 386.1503.

7-(2-Chlorophenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3h). White solid, R = 0.59, m.p. 210–212 °C. IR (KBr, cm−1) ν: 3041, 2957, 1651, 1518, 1491, 1458, 1069, 821, 771. 1H-NMR (400 MHz, CDCl3) δ 8.15 (d, J = 6.8 Hz, 1H, ArH), 7.67–7.59 (m, 3H, ArH), 7.53–7.49 (m, 4H, ArH), 7.23 (d, J = 6.4 Hz, 1H, ArH), 6.76 (d, J = 6.8 Hz, 1H, ArH), 2.52–2.46 (m, 4H, 2 × CH2), 1.14–1.11 (m, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.8, 147.5, 139.5, 135.1, 132.3, 132.1, 131.7, 131.0, 130.8, 129.3, 129.2, 128.7, 128.2, 128.1, 126.7, 126.4, 126.0, 125.5, 124.0, 118.4, 116.2, 52.2, 36.4, 35.9, 29.0, 28.2. HRMS (ESI) m/z: Calcd. for C26H20ClNONa [M + Na]+ 420.1131. Found: 420.1169.

7-(4-(tert-Butyl)phenyl)-9,9-dimethyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3i). White solid, R = 0.56, m.p. 250–252 °C. IR (KBr, cm−1) ν: 3021, 2940, 1700, 1452, 1339, 1057, 893, 767. 1H-NMR (400 MHz, CDCl3) δ 8.18 (d, J = 5.6 Hz, 1H, ArH), 7.64–7.54 (m, 5H, ArH), 7.47–7.45 (m, 2H, ArH), 7.31–7.29 (t, J = 4.8 Hz, 1H, ArH), 7.13 (d, J = 6.0 Hz, 1H, ArH), 2.67 (s, 2H CH2), 2.48 (s, 2H, CH2), 1.44 (s, 9H, C(CH3)3), 1.14 (s, 6H, 2 × CH3). 13C-NMR (75 MHz, CDCl3) δ 193.8, 151.8, 146.6, 139.0, 134.7, 132.0, 131.9, 129.2, 129.1, 128.1, 126.6, 126.3, 126.0, 125.2, 123.8, 119.0, 116.3, 52.1, 37.2, 35.8, 34.9, 31.4, 28.6. HRMS (ESI) m/z: Calcd. for C30H28NO [M − H]+ 418.2171. Found: 418.2147.

7-Phenyl-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3j). White solid, R = 0.57, m.p. 208–210 °C. IR (KBr, cm−1) ν: 3038, 2956, 1720, 1698, 1498, 1341, 1136, 837, 734. 1H-NMR (400 MHz, CDCl3) δ 8.10 (d, J = 6.0 Hz, 1H, ArH), 7.56–7.43 (m, 8H, ArH), 7.18 (d, J = 7.2 Hz, 1H, ArH), 7.01 (d, J = 6.0 Hz, 1H, ArH), 2.67 (s, 2H, CH2), 2.51 (s, 2H, CH2), 2.07 (s, 2H, CH2). 13C-NMR (75 MHz, CDCl3) δ 194.4, 147.6, 138.7, 137.4, 132.0, 131.9, 129.8, 129.2, 128.9, 128.6, 128.1, 126.6, 126.4, 126.1, 126.0, 125.7, 123.9, 119.0, 117.4, 38.1, 24.0, 23.3. HRMS(ESI) m/z: Calcd. for C24H16NO [M − H]+ 334.1232. Found 334.1234.

7-(2-Chlorophenyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3k). White solid, R = 0.39, m.p. 193–194 °C. IR (KBr, cm−1) ν: 3051, 2943, 1723, 1656, 1522, 1072, 820, 773, 745. 1H-NMR (400 MHz, CDCl3) δ 8.10 (d, J = 6.4 Hz, 1H, ArH), 7.55–7.51 (m, 3H, ArH), 7.47–7.38 (m, 4H, ArH), 7.16 (t, J = 7.2 Hz, 1H, ArH), 6.71 (d, J = 6.8 Hz, 1H, ArH), 2.61–2.50 (m, 4H, 2 × CH2), 2.09–2.05 (m, 2H, CH2). 13C- NMR (75 MHz, CDCl3) δ 194.4, 148.6, 139.3, 135.0, 132.1, 131.7, 131.0, 130.8, 129.2, 129.1, 128.7, 128.2, 128.1, 126.7, 126.4, 126.0, 125.7, 123.9, 118.5, 117.4, 38.1, 23.8, 22.6. HRMS (ESI) m/z: Calcd. for C24H16ClNONa [M + Na]+ 392.0818. Found: 392.0830.

7-(2,4-Dimethylphenyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3l). White solid, R = 0.35, m.p. 264–267 °C. IR (KBr, cm−1) ν: 3037, 2943, 1724, 1690, 1461, 1337, 1156, 788. 1H-NMR (400 MHz, CDCl3) δ 8.21–8.19 (m, 1H, ArH), 7.66–7.56 (m, 5H, ArH), 7.51–7.44 (m, 2H, ArH), 7.31 (t, 1H, J = 4.8 Hz, ArH), 7.15 (d, J = 6.0 Hz, 1H, ArH), 2.84–2.79 (m, 2H, CH2), 2.64–2.58 (m, 2H, CH2), 2.22–2.15 (m, 2H, CH2), 1.42 (s, 9H, 3 × CH3). 13C-NMR (75 MHz, CDCl3) δ 194.5, 151.8, 147.8, 138.7, 134.6, 132.1, 131.9, 129.2, 129.0, 128.1, 126.6, 126.3, 126.0, 125.1, 123.8, 119.1, 117.3, 38.1, 34.9, 31.4, 24.0, 23.4. HRMS calcd for C28H25NONa [M + Na]+ 414.1834, found 414.1834.

7-(4-(tert-Butyl)phenyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3m). White solid, R = 0.36, m.p. 190–192 °C. IR (KBr, cm−1) ν: 3049, 2953, 1655, 1521, 1082, 819, 773. 1H-NMR (400 MHz, CDCl3) δ 8.17 (d, J = 6.4 Hz, 1H, ArH), 7.64–7.59 (m, 2H, ArH), 7.53 (t, J = 7.2 Hz, 1H, ArH), 7.25–7.22 (m, 3H, ArH), 7.17 (d, J = 8.0 Hz, 1H, ArH), 6.76 (d, J = 6.8 Hz, 1H, ArH), 2.67 (t, J = 10.4 Hz, 1H, CH2), 2.62–2.59 (m, 2H, CH2), 2.53 (t, J = 5.6 Hz, 1H, CH2), 2.44 (s, 3H, CH3), 2.18–2.15 (m, 2H, CH2), 2.07 (s, 3H, CH3). 13C-NMR (75 MHz, CDCl3) δ 194.3, 148.1, 139.5, 135.2, 133.7, 132.3, 132.1, 131.8, 129.2, 129.0, 128.2, 127.9, 127.2, 126.7, 126.2, 125.8, 123.7, 118.3, 117.0, 38.2, 24.0, 22.6, 21.3, 17.4. HRMS (ESI) m/z: Calcd. for C26H21NONa [M + Na]+ 386.1521. Found: 386.1566.

7-(3,5-Dimethylphenyl)-9,10-dihydro-7H-acenaphtho[1,2-b]indol-11(8H)-one (3n). White solid, R = 0.34, m.p. 222–224. IR (KBr, cm−1) ν: 3043, 2940, 1721, 1660, 1521, 1071, 1034, 852, 815, 767. 1H-NMR (400 MHz, CDCl3) δ 8.19–8.17 (m, 1H, ArH), 7.66–7.62 (m, 2H, ArH), 7.56–7.51 (m, 1H, ArH), 7.31–7.28 (m, 1H, ArH), 7.17–7.11 (m, 4H, ArH), 2.81 (t, J = 5.2 Hz, 2H, CH2), 2.63–2.59 (m, 2H, CH2), 2.44 (s, 6H, 2 × CH3), 2.19 (t, J = 5.6 Hz, 2H, CH2). 13C-NMR (75 MHz, CDCl3) δ 194.5, 147.7, 139.6, 138.8, 137.2, 132.1, 131.9, 130.2, 129.2, 129.1, 128.1, 126.7, 126.3, 126.0, 123.8, 123.3, 118.9, 117.3, 38.1, 24.0, 23.4, 21.4. HRMS (ESI) m/z: Calcd. for C26H20NO [M − H]+ 363.1545. Found: 363.1557.

3.3. General Procedure for the Synthesis of Tetrahydroacenaphtho[1,2-b]indole Derivatives Fa

A mixture of enaminone (1a) (1.0 mmol), acenaphthoquinone (2) (1.0 mmol), l-proline (0.1 mmol) and toluene (5 mL) was refluxed for 3 h. After the completion of the reaction (confirmed by TLC), the reaction mixture was concentrated in vacuo. The crude mixture was purified by column chromatography on silica gel using ethyl acetate/petroleum ether 1:1 as the eluents to give corresponding product Fa.

6b,11b-Dihydroxy-9,9-dimethyl-7-(p-tolyl)-8,9,10,11b-tetrahydro-6bH-acenaphtho[1,2-b]indol-11(7H)-one (Fa). White solid, R = 0.23, m.p. 240–242 °C. IR (KBr, cm−1) ν: 3598, 2961, 2870, 1790, 1606, 1511, 1436, 1406, 1283, 1038, 783. 1H NMR (300 MHz, DMSO-d6) δ 7.94–6.93 (m, 10H, ArH), 6.46 (s, 1H, OH), 5.80 (s, 1H, OH), 2.38–1.79 (m, 7H, CH3 + 2 × CH2), 1.01 (s, 3H, CH3), 0.83 (s, 3H, CH3). 13C NMR (100 MHz, DMSO-d6) δ 194.5, 168.6, 149.7, 145.7, 142.4, 140.9, 139.8, 136.0, 135.0, 134.9, 134.2, 133.8, 132.7, 130.1, 128.6, 126. 6, 124.8, 115.9, 107.8, 91.9, 56.3, 42.3, 38.7, 34.7, 32.3, 26.2. HRMS (ESI) m/z: Calcd. for C27H25NO3Na [M + Na]+ 434.1732. Found: 434.1734.

4. Conclusions

In summary, we have developed an efficient protocol for the construction of acenaphtho[1,2-b]indole derivatives via the domino reaction of enaminones with acenaphthoquinone catalyzed by l-proline. This protocol has the advantages of mild reaction conditions, high yields and operational convenience.